Skip Header

1 - 25 of 57 results for author:"Spies T." in Literature citations

Page of 3 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (48)

Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding.

Huergo-Zapico L., Gonzalez-Rodriguez A.P., Contesti J., Gonzalez E., Lopez-Soto A., Fernandez-Guizan A., Acebes-Huerta A., de Los Toyos J.R., Lopez-Larrea C., Groh V. et al.

Cancer Immunol. Immunother. 61:1201-1210(2012) · Mapped (52)

Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression.

Xu X., Rao G.S., Groh V., Spies T., Gattuso P., Kaufman H.L., Plate J., Prinz R.A.

BMC Cancer 11:194-194(2011) · Mapped (55)

Crystal structure of a gammadelta T-cell receptor specific for the human MHC class I homolog MICA.

Xu B., Pizarro J.C., Holmes M.A., McBeth C., Groh V., Spies T., Strong R.K.

Proc. Natl. Acad. Sci. U.S.A. 108:2414-2419(2011) · Mapped (46)

NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.

Hanaoka N., Jabri B., Dai Z., Ciszewski C., Stevens A.M., Yee C., Nakakuma H., Spies T., Groh V.

J. Immunol. 185:5732-5742(2010) · Mapped (2)

Conserved amino acids within the adenovirus 2 E3/19K protein differentially affect downregulation of MHC class I and MICA/B proteins.

Sester M., Koebernick K., Owen D., Ao M., Bromberg Y., May E., Stock E., Andrews L., Groh V., Spies T. et al.

J. Immunol. 184:255-267(2010) · Mapped (55)

Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus.

Dai Z., Turtle C.J., Booth G.C., Riddell S.R., Gooley T.A., Stevens A.M., Spies T., Groh V.

J. Exp. Med. 206:793-805(2009) · Mapped (2)

Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15.

Tang F., Chen Z., Ciszewski C., Setty M., Solus J., Tretiakova M., Ebert E., Han J., Lin A., Guandalini S. et al.

J. Exp. Med. 206:707-719(2009) · Mapped (6)

Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis.

Capraru D., Muller A., Csernok E., Gross W.L., Holl-Ulrich K., Northfield J., Klenerman P., Herlyn K., Holle J., Gottschlich S. et al.

Clin. Immunol. 127:144-150(2008) · Mapped (2)

Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands MICA and MICB.

McSharry B.P., Burgert H.-G., Owen D.P., Stanton R.J., Prod'homme V., Sester M., Koebernick K., Groh V., Spies T., Cox S.T. et al.

J. Virol. 82:4585-4594(2008) · UniProtKB (1) · Mapped (56)

Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.

Kaiser B.K., Yim D., Chow I.-T., Gonzalez S., Dai Z., Mann H.H., Strong R.K., Groh V., Spies T.

Nature 447:482-486(2007) · UniProtKB (2) · Mapped (48)

Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D.

Venkataraman G.M., Suciu D., Groh V., Boss J.M., Spies T.

J. Immunol. 178:961-969(2007) · Mapped (11)

Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.

Groh V., Smythe K., Dai Z., Spies T.

Nat. Immunol. 7:755-762(2006) · Mapped (2)

Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1-associated neurologic disease.

Azimi N., Jacobson S., Tanaka Y., Corey L., Groh V., Spies T.

Immunogenetics 58:252-258(2006) · Mapped (57)

Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.

Wiemann K., Mittruecker H.-W., Feger U., Welte S.A., Yokoyama W.M., Spies T., Rammensee H.-G., Steinle A.

J. Immunol. 175:720-729(2005) · UniProtKB (1) · Mapped (50)

HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.

Carbone E., Neri P., Mesuraca M., Fulciniti M.T., Otsuki T., Pende D., Groh V., Spies T., Pollio G., Cosman D. et al.

Blood 105:251-258(2005) · Mapped (6)

Clonal expansion of double-positive intraepithelial lymphocytes by MHC class I-related chain A expressed in mouse small intestinal epithelium.

Park E.J., Takahashi I., Ikeda J., Kawahara K., Okamoto T., Kweon M.N., Fukuyama S., Groh V., Spies T., Obata Y. et al.

J. Immunol. 171:4131-4139(2003) · Mapped (46)

Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid.

Jinushi M., Takehara T., Tatsumi T., Kanto T., Groh V., Spies T., Kimura R., Miyagi T., Mochizuki K., Sasaki Y. et al.

Int. J. Cancer 104:354-361(2003) · UniProtKB (1) · Mapped (54)

Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection.

Jinushi M., Takehara T., Kanto T., Tatsumi T., Groh V., Spies T., Miyagi T., Suzuki T., Sasaki Y., Hayashi N.

J. Immunol. 170:1249-1256(2003) · UniProtKB (1) · Mapped (54)

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.

Groh V., Wu J., Yee C., Spies T.

Nature 419:734-738(2002) · UniProtKB (1) · Mapped (56)

Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.

Steinle A., Li P., Morris D.L., Groh V., Lanier L.L., Strong R.K., Spies T.

Immunogenetics 53:279-287(2001) · UniProtKB (5) · Mapped (1)

MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function.

Das H., Groh V., Kuijl C., Sugita M., Morita C.T., Spies T., Bukowski J.F.

Immunity 15:83-93(2001) · UniProtKB (1)

Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA.

Li P., Morris D.L., Willcox B.E., Steinle A., Spies T., Strong R.K.

Nat. Immunol. 2:443-451(2001) · UniProtKB (1) · Mapped (1)

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.

Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., Spies T.

Nat. Immunol. 2:255-260(2001) · UniProtKB (1)

DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells.

Wu J., Cherwinski H., Spies T., Phillips J.H., Lanier L.L.

J. Exp. Med. 192:1059-1068(2000) · UniProtKB (1)

Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice.

Grandea A.G., Golovina T.N., Hamilton S.E., Sriram V., Spies T., Brutkiewicz R.R., Harty J.T., Eisenlohr L.C., Van Kaer L.

Immunity 13:213-222(2000) · Mapped (27)

to top of page·

Page of 3 | Next »